课题基金 / 基金详情

Ouabain and Descending Vasa Recta Ca2+ Signaling

Ouabain and Descending Vasa Recta Ca2+ Signaling
哇巴因和降支直肠 Ca2 信号传导
批准号:
7858349
负责人:
THOMAS L PALLONE
金额:
$42.78万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

THOMAS L PALLONE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The microcirculation of the renal medulla traps NaCI and urea deposited to the interstitium by the loops of Henle and collecting ducts and distributes blood flow to a hypoxic region of the kidney. Evidence links medullary perfusion to regulation of salt and water excretion, hypertension and genesis of acute renal failure. Descending vasa recta (DVR) are 15 mu m arteriolar microvessels through which blood flow reaches the renal medulla. DVR vasoactivity is controlled by contractile pericytes and adjacent endothelia. We have established methods to study Ca 2+ signaling and channel architecture in those cells. Past studies have shown that endothelial Ca 2+signaling is stimulated by vasodilators and inhibited by angiotensin II. Preliminary data verifies that maneuvers affecting cellular Na+ (Na+/K + ATPase inhibition and extracellular Na + reduction) strongly modulate DVR endothelial Ca 2+. We will test the hypothesis that high ouabain affinity Na + pump isoforms and Na+/Ca 2+ exchange (NCX) modulate DVR endothelial Ca 2+signaling, participate in Angll signaling and become deranged in the chronic ouabain hypertensive rat. In Aim 1, we will test whether Na+K+ATPase high affinity isoforms (alpha2/alpha3) and NCX are sequestered in subplasmalemmal microdomains that affect Ca 2+signaling. We will examine colocalization of signaling proteins with SR/ER using immunofluorescence. We will determine whether ouabain inhibition, alpha2Na+ pump deficiency, reduction of extracellular Na+ ([Na+]e) and NCX blockade modulate DVR endothelial [Ca 2+]CYT responses to vasodilators. In Aim 2, we will use low affinity fluorescent probes (furaFF, furaptra) to determine the effect of the maneuvers in Aim 1 on store Ca2+ sequestration. In Aim 3, we will investigate the mechanisms responsible for Angll inhibition of DVR endothelial [Ca2+]CYT responses to sarcoplasmic / endoplasmic release Ca 2+(SERCA) pump inhibition and vasodilators. We will characterize Ca 2+ entry pathways in DVR endothelia and test whether Angll inhibits them. We will test for roles of NCX and Ca 2+ store sequestration in the Angll induced reduction of endothelial [Ca2+]CYT. In Aim 4 we will follow up our observation that DVR endothelial dysfunction accompanies chronic ouabain hypertension (OH) in the rat. We will test whether endothelial Ca 2+ responses and NO release are altered in OH rats and whether Na+ pump isoforms are down-regulated. We will test whether DVR contractions to norepinephrine, Angll and KCI are increased, measure NO production and assess effects of OH on endothelial and pericyte Ca2+ signaling.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Microvascular Transport in the Renal Medulla
  • 批准号:
    7987443
  • 项目类别:
  • 资助金额:
    $5.65万
  • 财政年份:
    2009
  • 负责人:
    THOMAS L PALLONE
  • 依托单位:
Reactive Oxygen Species American Society of Nephrology Fall 2007
  • 批准号:
    7407302
  • 项目类别:
  • 资助金额:
    $1.0万
  • 财政年份:
    2007
  • 负责人:
    THOMAS L PALLONE
  • 依托单位:
Ouabain and Descending Vasa Recta Ca2+ Signaling
  • 批准号:
    6968176
  • 项目类别:
  • 资助金额:
    $37.85万
  • 财政年份:
    2004
  • 负责人:
    THOMAS L PALLONE
  • 依托单位:
Calcium Signaling in Vasa Recta Endothelium
  • 批准号:
    6806087
  • 项目类别:
  • 资助金额:
    $30.44万
  • 财政年份:
    2004
  • 负责人:
    THOMAS L PALLONE
  • 依托单位:
国内基金
海外基金
TMEM8B-a 多聚化修饰降解 ATP2A2 蛋白抑制肺癌细胞集体侵袭的分子机制及靶向抑制剂转化应用研究
  • 批准号:
    2022JJ10096
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2022
  • 负责人:
    王理
  • 依托单位:
基于单细胞测序解析miR-4632靶向ATP2A2调控NLRP3焦亡信号促进肺动脉高压血管重塑的作用机制研究
  • 批准号:
    82241015
  • 项目类别:
    专项项目
  • 资助金额:
    50.00万元
  • 批准年份:
    2022
  • 负责人:
    缪冉
  • 依托单位:
TMEM8B-a多聚化修饰降解ATP2A2蛋白抑制肺癌细胞集体侵袭的分子机制及相应靶向抑制剂转化应用研究
  • 批准号:
    82172879
  • 项目类别:
    面上项目
  • 资助金额:
    55万元
  • 批准年份:
    2021
  • 负责人:
    王理
  • 依托单位:
重度智力障碍并癫痫候选易感/致病基因ATP2A2、RYR1和RYR2分析验证及发病机制的研究
  • 批准号:
    81771408
  • 项目类别:
    面上项目
  • 资助金额:
    70.0万元
  • 批准年份:
    2017
  • 负责人:
    尹飞
  • 依托单位: